You are requesting information on: Versatile Lipid Nanoparticle Platform For Efficient CRISPR-Cas9 Gene Editing In Primary T-Cells And CD34 Hematopoietic Stem Cells Cytiva
Already a member of Advancing RNA or VertMarkets? Sign in now.
In order for our suppliers to better serve your request, please enter specific requirements or questions below:
